Trial Assessing Efficacy, Safety and Tolerability of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition in Paediatric Subjects With Genetic Low-Density Lipoprotein (LDL) Disorders

Research Site, Ljubljana

Research Site, Vienna

Research Site, Budapest

Research Site, Brussels

Research Site, Geneva

Research Site, Camperdown

Research Site, Leuven

Research Site, Reinach

Research Site, Salzburg

Research Site, Bergen

Research Site, Feldkirch

Research Site, La Louvière

Research Site, Parow

Research Site, Christchurch

Research Site, Torino

Research Site, The Bronx

Research Site, Taipei

Research Site, Córdoba

Research Site, A Coruña

Research Site, Pittsburgh

Research Site, Kota Bharu

Research Site, Athens

Research Site, Wilmington

Research Site, Towson

Research Site, Morgantown

Research Site, Lugo

Research Site, Asheville

Research Site, Izmir

Research Site, Nashville

Research Site, Seville

Research Site, Cincinnati

Research Site, Iowa City

Research Site, Thessaloniki

Research Site, Minneapolis

Research Site, Pisa

Research Site, Kuopio

Research Site, Salt Lake City

Research Site, Palermo

Research Site, Moscow

Research Site, Saint Petersburg

Research Site, Farmington

Research Site, Fortaleza

Research Site, Vitória

Research Site, Brasília

Research Site, São Paulo

Research Site, São Paulo

Research Site, Chicoutimi

Research Site, Chicoutimi

Research Site, Québec

Research Site, Barranquilla

Research Site, Floridablanca

Research Site, Ostrava-Poruba

Research Site, Prague

Research Site, Svitavy

Research Site, Helsinki

Research Site, Roma

Research Site, Roma

Research Site, Amsterdam

Research Site, Oslo

Research Site, Gdansk

Research Site, Guimarães

Research Site, Pretoria

Research Site, Barcelona

Research Site, Ankara

Research Site, Birmingham

Research Site, London